Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T34234 | Target Info | |||
Target Name | Vitamin D3 receptor (VDR) | ||||
Synonyms | Vitamin D(3) receptor; Nuclear vitamin D receptor; Nuclear receptor subfamily 1 group I member 1; NR1I1; 1,25-dihydroxyvitamin D3 receptor | ||||
Target Type | Successful Target | ||||
Gene Name | VDR | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | (1r,2s,3r)-5-[2-[(1r,3as,7ar)-1-[(2r)-6-Hydroxy-6-Methyl-Heptan-2-Yl]-7a-Methyl-1,2,3,3a,6,7-Hexahydroinden-4-Yl]ethynyl]-2-Methyl-Cyclohex-4-Ene-1,3-Diol | Ligand Info | |||
Canonical SMILES | CC1C(CC(=CC1O)C#CC2=CCCC3(C2CCC3C(C)CCCC(C)(C)O)C)O | ||||
InChI | 1S/C27H42O3/c1-18(8-6-14-26(3,4)30)22-12-13-23-21(9-7-15-27(22,23)5)11-10-20-16-24(28)19(2)25(29)17-20/h9,16,18-19,22-25,28-30H,6-8,12-15,17H2,1-5H3/t18-,19-,22-,23-,24-,25-,27-/m1/s1 | ||||
InChIKey | YCBJWNMIMDLOPD-ADFBMCJESA-N | ||||
PubChem Compound ID | 53261165 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3AUR Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2beta-methyl-19-norvitamin D3 | ||||||
Method | X-ray diffraction | Resolution | 2.21 Å | Mutation | No | [1] |
PDB Sequence |
DSLRPKLSEE
127 QQRIIAILLD137 AHHKTYDPTY147 SDFCQFRPPV157 RVNDGSVTLE220 LSQLSMLPHL 230 ADLVSYSIQK240 VIGFAKMIPG250 FRDLTSEDQI260 VLLKSSAIEV270 IMLRSNESFT 280 MDDMSWTCGN290 QDYKYRVSDV300 TKAGHSLELI310 EPLIKFQVGL320 KKLNLHEEEH 330 VLLMAICIVS340 PDRPGVQDAA350 LIEAIQDRLS360 NTLQTYIRCR370 HPPPGSHLLY 380 AKMIQKLADL390 RSLNEEHSKQ400 YRCLSFQPEC410 SMKLTPLVLE420 VFG |
|||||
|
TYR143
2.742
TYR147
3.791
PHE150
3.843
LEU227
3.428
LEU230
4.225
LEU233
3.597
VAL234
3.977
TYR236
4.531
SER237
2.797
ILE268
3.954
ILE271
4.181
MET272
4.010
ARG274
2.869
SER275
3.389
GLU277
4.894
|
|||||
PDB ID: 3AUQ Crystal structure of the human vitamin D receptor ligand binding domain complexed with Yne-diene type analog of active 14-epi-2alpha-methyl-19-norvitamin D3 | ||||||
Method | X-ray diffraction | Resolution | 2.64 Å | Mutation | No | [1] |
PDB Sequence |
DSLRPKLSEE
127 QQRIIAILLD137 AHHKTYDPTY147 SDFCQFRPPV157 RVNDGSVTLE220 LSQLSMLPHL 230 ADLVSYSIQK240 VIGFAKMIPG250 FRDLTSEDQI260 VLLKSSAIEV270 IMLRSNESFT 280 MDDMSWTCGN290 QDYKYRVSDV300 TKAGHSLELI310 EPLIKFQVGL320 KKLNLHEEEH 330 VLLMAICIVS340 PDRPGVQDAA350 LIEAIQDRLS360 NTLQTYIRCR370 HPPPGSHLLY 380 AKMIQKLADL390 RSLNEEHSKQ400 YRCLSFQPEC410 SMKLTPLVLE420 VFG |
|||||
|
TYR143
2.806
TYR147
3.828
PHE150
3.635
LEU227
3.708
LEU230
4.010
LEU233
3.874
VAL234
3.740
TYR236
4.714
SER237
2.703
ILE268
3.882
ILE271
3.902
MET272
3.953
ARG274
2.854
SER275
3.357
ASN276
4.952
GLU277
4.890
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Development of 14-epi-19-nortachysterol and its unprecedented binding configuration for the human vitamin D receptor. J Am Chem Soc. 2011 May 11;133(18):7215-21. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.